The Trump administration is preparing to impose 100% tariffs on imports of patented medications and their active ingredients, according to a draft executive order obtained by STAT and first reported by Bloomberg. The tariffs could be announced as soon as Thursday, April 3, 2026, though both the timeline and specific details remain subject to change. The order includes several paths for exemptions from the tariff requirements. If implemented without exemptions, the tariffs could potentially double the cost of affected pharmaceutical products for consumers and healthcare providers.
Story comments
Loading comments…